157 related articles for article (PubMed ID: 23999057)
1. Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain.
Ungard RG; Seidlitz EP; Singh G
Pain; 2014 Jan; 155(1):28-36. PubMed ID: 23999057
[TBL] [Abstract][Full Text] [Related]
2. The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.
Slosky LM; BassiriRad NM; Symons AM; Thompson M; Doyle T; Forte BL; Staatz WD; Bui L; Neumann WL; Mantyh PW; Salvemini D; Largent-Milnes TM; Vanderah TW
Pain; 2016 Nov; 157(11):2605-2616. PubMed ID: 27482630
[TBL] [Abstract][Full Text] [Related]
3. xCT knockdown in human breast cancer cells delays onset of cancer-induced bone pain.
Ungard RG; Linher-Melville K; Nashed MG; Sharma M; Wen J; Singh G
Mol Pain; 2019; 15():1744806918822185. PubMed ID: 30799686
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting STAT3 in a murine model of human breast cancer-induced bone pain delays the onset of nociception.
Linher-Melville K; Sharma M; Nakhla P; Kum E; Ungard R; Park J; Rosa D; Gunning P; Singh G
Mol Pain; 2019; 15():1744806918823477. PubMed ID: 30799695
[TBL] [Abstract][Full Text] [Related]
5. Functional effects of TrkA inhibition on system x
Miladinovic T; Ungard RG; Linher-Melville K; Popovic S; Singh G
Mol Pain; 2018; 14():1744806918776467. PubMed ID: 29761734
[TBL] [Abstract][Full Text] [Related]
6. The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine.
Guan J; Lo M; Dockery P; Mahon S; Karp CM; Buckley AR; Lam S; Gout PW; Wang YZ
Cancer Chemother Pharmacol; 2009 Aug; 64(3):463-72. PubMed ID: 19104813
[TBL] [Abstract][Full Text] [Related]
7. High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells.
Thomas AG; Sattler R; Tendyke K; Loiacono KA; Hansen H; Sahni V; Hashizume Y; Rojas C; Slusher BS
PLoS One; 2015; 10(8):e0127785. PubMed ID: 26252954
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of glutamate release from breast cancer cells; new targets for cancer-induced bone-pain.
Fazzari J; Lin H; Murphy C; Ungard R; Singh G
Sci Rep; 2015 Feb; 5():8380. PubMed ID: 25670024
[TBL] [Abstract][Full Text] [Related]
9. CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer.
Kim EH; Shin D; Lee J; Jung AR; Roh JL
Cancer Lett; 2018 Sep; 432():180-190. PubMed ID: 29928961
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and cancer pain.
Ungard RG; Seidlitz EP; Singh G
Can J Physiol Pharmacol; 2013 Jan; 91(1):31-7. PubMed ID: 23368277
[TBL] [Abstract][Full Text] [Related]
11. The X
Zheng Z; Luo G; Shi X; Long Y; Shen W; Li Z; Zhang X
Cell Oncol (Dordr); 2020 Feb; 43(1):95-106. PubMed ID: 31617161
[TBL] [Abstract][Full Text] [Related]
12. Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy.
Doxsee DW; Gout PW; Kurita T; Lo M; Buckley AR; Wang Y; Xue H; Karp CM; Cutz JC; Cunha GR; Wang YZ
Prostate; 2007 Feb; 67(2):162-71. PubMed ID: 17075799
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.
Evonuk KS; Baker BJ; Doyle RE; Moseley CE; Sestero CM; Johnston BP; De Sarno P; Tang A; Gembitsky I; Hewett SJ; Weaver CT; Raman C; DeSilva TM
J Immunol; 2015 Jul; 195(2):450-463. PubMed ID: 26071560
[TBL] [Abstract][Full Text] [Related]
14. Autocrine glutamate signaling promotes glioma cell invasion.
Lyons SA; Chung WJ; Weaver AK; Ogunrinu T; Sontheimer H
Cancer Res; 2007 Oct; 67(19):9463-71. PubMed ID: 17909056
[TBL] [Abstract][Full Text] [Related]
15. Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression.
Nashed MG; Ungard RG; Young K; Zacal NJ; Seidlitz EP; Fazzari J; Frey BN; Singh G
Sci Rep; 2017 Jan; 7():41382. PubMed ID: 28120908
[TBL] [Abstract][Full Text] [Related]
16. Sulfasalazine attenuates ACL transection and medial menisectomy-induced cartilage destruction by inhibition of cystine/glutamate antiporter.
Tsai WY; Tsai RY; Liu CC; Wu JL; Wong CS
J Orthop Res; 2016 Apr; 34(4):650-7. PubMed ID: 26466556
[TBL] [Abstract][Full Text] [Related]
17. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Roh JL; Kim EH; Jang HJ; Park JY; Shin D
Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
[TBL] [Abstract][Full Text] [Related]
18. Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange.
Ye ZC; Rothstein JD; Sontheimer H
J Neurosci; 1999 Dec; 19(24):10767-77. PubMed ID: 10594060
[TBL] [Abstract][Full Text] [Related]
19. Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of Doxorubicin.
Narang VS; Pauletti GM; Gout PW; Buckley DJ; Buckley AR
Chemotherapy; 2007; 53(3):210-7. PubMed ID: 17356269
[TBL] [Abstract][Full Text] [Related]
20. System X
Nehser M; Dark J; Schweitzer D; Campbell M; Zwicker J; Hitt DM; Little H; Diaz-Correa A; Holley DC; Patel SA; Thompson CM; Bridges RJ
Neurochem Res; 2020 Jun; 45(6):1375-1386. PubMed ID: 31754956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
